4. At admission, 41% of patients were on heart failure-exacerbating medications, and at discharge, 36% were. ... only in certain circumstances or have more recent data to support their use in heart failure patients.
In diastolic heart failure, the EF is normal (55% to 70%) or elevated (>70%). ... HFrEF and HFpEF are acceptable descriptions of systolic and diastolic heart failure, respectively.
The results of the study were published Aug. 12 by JACC: Heart Failure. ... Overall, 22,677 patients hospitalized for heart failure with reduced ejection fraction were included in the study.
A 57-year-old woman is evaluated in the hospital for chronic systolic heart failure. ... The routine treatment of patients with heart failure with warfarin is not indicated.
Researchers couldn't determine whether women with heart failure were less likely to be hospitalized or to receive intensive or invasive care due to undertreatment of women or overtreatment of men ... Among 396,024 decedents with heart failure, mean age
These results suggest that in a month with high influenza activity, about 19% (95% CI, 10% to 28%) of heart failure hospitalizations could be attributable to influenza. ... Addressing influenza activity may be valuable in efforts to prevent [heart failure
The study's primary outcomes were heart failure readmission, all-cause readmission, and all-cause mortality. ... Almost half (46%) of patients who received heart failure medication had no post-discharge dose escalation.
An equation that predicts natriuretic response based on a spot urine sample after diuretic administration could help improve diuretic therapy in patients with acute decompensated heart failure, a recent study found. ... They concluded that the NPRE can
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. ... A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
The primary outcomes of the study were all-cause death and heart failure readmission. ... Overall, 397 patients (11.1%) were readmitted for heart failure within 90 days of the index admission.